Long Read Sequencing Market Size to Hit US$ 5,334.68 million by 2028

The long read sequencing is a DNA sequencing technique. It offers numerous distinct advantages than next-generation sequencing technologies such as more precisely sequence DNA containing the same sections of DNA repeated within the genome. Many adults aged 60 years and above suffer from two or more chronic illnesses. Genes play a role in chronic diseases such as cardiovascular disease, diabetes, obesity, RA, Alzheimer's disease (AD), and depression, according to twin research. According to the Centers for Disease Control and Prevention (CDC), about 6 out of 10 individuals in the US are affected by at least one chronic disease, as well as 4 out of 10 are suffering from two or more chronic diseases.

The long read sequencing market was valued at US$ 1,101.15 million in 2020 and it is projected to reach US$ 5,334.68 million by 2028; it is expected to grow at a CAGR of 22.3% during 2021-2028.

Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00006815/?utm_source=OpenPR&utm_medium=10357

Oxford Nanopore Technologies; Tataa Biocenter; Illumina, Inc; Perkinelmer Inc.; F. Hoffmann-La Roche Ltd.; Baseclear B.V.; Bionano Genomics; Longas Technologies; Pacific Biosciences of California, Inc.; and Quantapore, Inc are among the key players operating in the long read sequencing market. These companies focus on partnerships, mergers, product launches, and collaborations to sustain their positions in the market.

For instance, in January 2021, Illumina Announced new sequencing system, collaboration with Roche, and software suite to accelerate genomics adoption. Furthermore, Roche will work with Illumina to add additional companion diagnostic (CDx) statements to Illumina's robust pan-cancer assay TruSight Oncology 500 (TSO 500). Moreover, in March 2021, The Oxford Nanopore Ultra-Long DNA Sequencing Kit, when used in conjunction with Circulomics Nanobind Kits, is designed to maximise the number of ultra-long reads and has allowed the continuous sequencing of single DNA fragments of up to 3+ Mb externally and 4+ Mb internally. Using this method, users can achieve more than 100 reads over 1 Mb per PromethION flow cell run.

The report highlights trends prevailing in the global market, and drivers and restraints pertaining to the market growth. Factors such as the advantages of long read sequencing and increasing prevalence of chronic diseases fuel the growth of the long read sequencing market. However, the lack of skilled professionals hinders the market growth.

Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPRE00006815/?utm_source=OpenPR&utm_medium=10357

About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, chemicals etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.